In a July 24, 2020 letter to the editor entitled, “Insurers’ moves to limit telehealth amid COVID-19 are inhumane and must be stopped,” the authors use disjointed logic to reach an inaccurate conclusion.
It is obvious to virtually everyone in the United States that the numbers of patients affected with COVID-19 are continuing to escalate. The impact of this is obvious, with many patients dying or permanently damaged from this dangerous virus.
I enjoy your publication and read it cover to cover most weeks. But I must point out a glaring error in your recent edition of March 22. The illustrations accompanying the article about the Texas cancer researchers show saguaro cacti. Saguaro cacti only grow in the Sonoran desert of southern Arizona and western Sonora, Mexico, with a few stray saguaros in California. The saguaro cactus does not grow in Texas. It is a common misconception that the saguaro grows throughout the west. The cactus is so unique to Arizona that the saguaro cactus blossom has been named the state flower of Arizona. I thought you should be made aware of this inaccuracy.
I have had the privilege of accepting young men and women into medical oncology fellowship programs at Memorial Sloan Kettering Cancer Center, the University of Vermont Cancer Center and MD Anderson Cancer Center and I have watched many of them shine as they took on both academic and community oncology positions throughout the United States and the world.Waun Ki Hong was special.
To the Editor:One of the biggest questions that early-stage breast cancer patients face is whether they will benefit from chemotherapy treatment. Two large scale randomized clinical trials that implement genomic testing have positively addressed this question.
Despite reporting such a staggering frequency of “missed” gynecological cancer, it is concerning that the Yale authors, like most gynecologists, appear quite relaxed about this level of risk in their paper’s discussion—foremost because this level of oncological risk in women undergoing non-oncological operations is an iatrogenic mortality risk.
